Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Endometrial receptivity and implantation require uterine BMP signaling through an ACVR2A-SMAD1/SMAD5 axis.
Nat Commun. 2021 Jun 7;12(1):3386. doi: 10.1038/s41467-021-23571-5.
Nat Commun. 2021.
PMID: 34099644
Free PMC article.
Tumor suppressor PLK2 may serve as a biomarker in triple-negative breast cancer for improved response to PLK1 therapeutics.
Gao Y, Kabotyanski EB, Shepherd JH, Villegas E, Acosta D, Hamor C, Sun T, Montmeyor-Garcia C, He X, Dobrolecki LE, Westbrook TF, Lewis MT, Hilsenbeck SG, Zhang XH, Perou CM, Rosen JM.
Gao Y, et al. Among authors: hamor c.
Cancer Res Commun. 2021 Dec;1(3):178-193. doi: 10.1158/2767-9764.crc-21-0106. Epub 2021 Dec 27.
Cancer Res Commun. 2021.
PMID: 35156101
Free PMC article.
Item in Clipboard
Single-Cell Analysis Unveils the Role of the Tumor Immune Microenvironment and Notch Signaling in Dormant Minimal Residual Disease.
Janghorban M, Yang Y, Zhao N, Hamor C, Nguyen TM, Zhang XH, Rosen JM.
Janghorban M, et al. Among authors: hamor c.
Cancer Res. 2022 Mar 1;82(5):885-899. doi: 10.1158/0008-5472.CAN-21-1230.
Cancer Res. 2022.
PMID: 34965936
Free PMC article.
Item in Clipboard
Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer.
Singh S, Lee N, Pedroza DA, Bado IL, Hamor C, Zhang L, Aguirre S, Hu J, Shen Y, Xu Y, Gao Y, Zhao N, Chen SH, Wan YW, Liu Z, Chang JT, Hollern D, Perou CM, Zhang XHF, Rosen JM.
Singh S, et al. Among authors: hamor c.
Cancer Res. 2022 Jun 15;82(12):2281-2297. doi: 10.1158/0008-5472.CAN-21-3714.
Cancer Res. 2022.
PMID: 35442423
Free PMC article.
Item in Clipboard
Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer.
Zhao N, Kabotyanski EB, Saltzman AB, Malovannaya A, Yuan X, Reineke LC, Lieu N, Gao Y, Pedroza DA, Calderon SJ, Smith AJ, Hamor C, Safari K, Savage S, Zhang B, Zhou J, Solis LM, Hilsenbeck SG, Fan C, Perou CM, Rosen JM.
Zhao N, et al. Among authors: hamor c.
J Clin Invest. 2023 Dec 15;133(24):e172503. doi: 10.1172/JCI172503.
J Clin Invest. 2023.
PMID: 37874652
Free PMC article.
Item in Clipboard
Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer.
Zhao N, Kabotyanski EB, Saltzman AB, Malovannaya A, Yuan X, Reineke LC, Lieu N, Gao Y, Pedroza DA, Calderon SJ, Smith AJ, Hamor C, Safari K, Savage S, Zhang B, Zhou J, Solis LM, Hilsenbeck SG, Fan C, Perou CM, Rosen JM.
Zhao N, et al. Among authors: hamor c.
bioRxiv [Preprint]. 2023 Sep 28:2023.09.28.559973. doi: 10.1101/2023.09.28.559973.
bioRxiv. 2023.
PMID: 37808840
Free PMC article.
Updated.
Preprint.
Item in Clipboard
Cite
Cite